Trial Profile
PS-QD Phase3 Clinical Study -Investigation to find new dosage and administration of mesalazine for the treatment of patients with Ulcerative Colitis in remission phase
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 May 2016
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors Kyorin Pharmaceutical
- 30 May 2016 New trial record